Recent

% | $
Quotes you view appear here for quick access.

Rosetta Genomics, Ltd. Message Board

SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    The Value of Good News

    by mikeedgar May 29, 2015 8:40 AM

    Not only sales, but with the partnerships they need to announce some basic terms. For all we know, it is costing ROSG to sign up these partners.

  • Reply to

    The Value of Good News

    by mikeedgar May 29, 2015 8:40 AM

    I think they need to announce some sales and marketing news. All of these announcements have been regarding pipeline and research. Maybe everyone is highly concerned about sales.

  • Reply to

    The Value of Good News

    by mikeedgar May 29, 2015 8:40 AM

    I agree with the lack of response on good news. But I believe they sold those shares that they registered there in the first days after the announcement. We will know on the next earnings report, but that is a long wait with no price action on the stock. 2225 shares sold in the first 1/2 hour of trading today, What's up with that? I am guessing that a large move is happening here shortly and I hope it is to the upside for a break out.

  • Since the semi-annual report in mid-March, I count 12 positive announcements related to ROSG. This includes patents, new tests, up-grades and partnerships. Since then, share price has moved up about 40 cents (3.30 to 3.70). Granted, none of the announcements had any dollar amounts associated with them, but still, it seems like anything positive is being significantly discounted. At about 3.3 cents average per "positive" it would seem we're in for a long wait until we get back to the last secondary price.

    What would help? If management announced that all of the shares they had planned to sell on the open market (to fund continuing operations) had been sold. Without that overhang, perhaps investors would see it as the bottom is in.

Must Watch
ROSG
2.45+0.11(+4.70%)Aug 27 3:57 PMEDT